JP2024515830A5 - - Google Patents
Info
- Publication number
- JP2024515830A5 JP2024515830A5 JP2023566515A JP2023566515A JP2024515830A5 JP 2024515830 A5 JP2024515830 A5 JP 2024515830A5 JP 2023566515 A JP2023566515 A JP 2023566515A JP 2023566515 A JP2023566515 A JP 2023566515A JP 2024515830 A5 JP2024515830 A5 JP 2024515830A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- degrees
- dose
- subject
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163181807P | 2021-04-29 | 2021-04-29 | |
| US63/181,807 | 2021-04-29 | ||
| PCT/US2022/026908 WO2022232494A1 (en) | 2021-04-29 | 2022-04-29 | Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating female |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515830A JP2024515830A (ja) | 2024-04-10 |
| JP2024515830A5 true JP2024515830A5 (https=) | 2025-05-09 |
Family
ID=81748326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566515A Pending JP2024515830A (ja) | 2021-04-29 | 2022-04-29 | 母乳を出している女性における大うつ病性障害および産後うつ病の処置における使用のための神経活性ステロイド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240216396A1 (https=) |
| EP (1) | EP4329769A1 (https=) |
| JP (1) | JP2024515830A (https=) |
| CN (1) | CN117580580A (https=) |
| AU (1) | AU2022267304A1 (https=) |
| CA (1) | CA3217866A1 (https=) |
| IL (1) | IL307980A (https=) |
| MX (1) | MX2023012728A (https=) |
| WO (1) | WO2022232494A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2882708A1 (en) | 2012-08-21 | 2014-02-27 | Sage Therapeutics, Inc. | Methods of treating epilepsy or status epilepticus |
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| EP3504189A1 (en) | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
| MA51046A (fr) | 2017-12-08 | 2021-03-17 | Sage Therapeutics Inc | Dérivés de 21-[4-cyano-pyrazol-1-yl]-19-nor-pregan-3. alpha-ol-20-one deutérés pour le traitement de troubles du snc |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| EP3504189A1 (en) | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
| WO2019051264A1 (en) * | 2017-09-07 | 2019-03-14 | Sage Therapeutics, Inc. | NEUROACTIVE STEROIDS AND METHODS OF USE |
| CA3103421A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| MX2021006985A (es) * | 2018-12-14 | 2021-09-08 | Praxis Prec Medicines Inc | Metodos para el tratamiento de la depresión. |
| KR20230041049A (ko) | 2020-07-20 | 2023-03-23 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드의 제형 및 이의 사용 방법 |
-
2022
- 2022-04-29 EP EP22724194.0A patent/EP4329769A1/en active Pending
- 2022-04-29 AU AU2022267304A patent/AU2022267304A1/en active Pending
- 2022-04-29 US US18/557,705 patent/US20240216396A1/en active Pending
- 2022-04-29 WO PCT/US2022/026908 patent/WO2022232494A1/en not_active Ceased
- 2022-04-29 CN CN202280045723.6A patent/CN117580580A/zh active Pending
- 2022-04-29 CA CA3217866A patent/CA3217866A1/en active Pending
- 2022-04-29 IL IL307980A patent/IL307980A/en unknown
- 2022-04-29 MX MX2023012728A patent/MX2023012728A/es unknown
- 2022-04-29 JP JP2023566515A patent/JP2024515830A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024515830A5 (https=) | ||
| JP2024515829A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| US11369654B2 (en) | Application method of Dendrobium candidum in preparing medicine for treating hypertension | |
| JP2007533687A5 (https=) | ||
| WO2020223431A1 (en) | Combination therapies comprising apremilast and tyk2 inhibitors | |
| CN116098917A (zh) | 核苷类化合物在治疗冠状病毒感染性疾病中的用途 | |
| JP2011190199A (ja) | 関節リウマチ薬 | |
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2016507500A5 (https=) | ||
| JP2023509698A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| JP2024510260A5 (https=) | ||
| WO2022166599A1 (zh) | Pqq 及其衍生物的新应用 | |
| JP2017508737A5 (https=) | ||
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| JP2019507786A5 (https=) | ||
| JP2024525897A5 (https=) | ||
| JP5341037B2 (ja) | 双極性障害を処置するための医薬を得るためのアゴメラチンの使用 | |
| JP2006505548A (ja) | Ｐｐａｒリガンドと抗酸化剤の会合および肥満の治療のためのその使用 | |
| JP4652689B2 (ja) | 骨再生を促進するカルモジュリンの使用 | |
| EP2509586B1 (en) | Mucoadhesive buccal tablets for the treatment of orofacial herpes | |
| JP2022526643A5 (https=) | ||
| JP2025505578A5 (https=) | ||
| US8592434B2 (en) | Mucoadhesive buccal tablets for the treatment of orofacial herpes |